Voyager Therapeutics Inc. (VYGR)
NASDAQ: VYGR
· Real-Time Price · USD
3.56
-0.28 (-7.29%)
At close: Aug 19, 2025, 3:59 PM
Voyager Therapeutics Revenue
Voyager Therapeutics reported an annual revenue of $80M, reflecting a -68% growth. For the quarter ending June 30, 2025, Voyager Therapeutics generated $5.2M in revenue.
Revenue (ttm)
80M
Revenue Growth
-68%
Price / Sales Ratio
4.09
Revenue / Employee
465.12K
Employees
172
Market Cap
197.75M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 80M | -68.00% |
| Dec 31, 2023 | 250.01M | +511.16% |
| Dec 31, 2022 | 40.91M | +9.33% |
| Dec 31, 2021 | 37.41M | -78.14% |
| Dec 31, 2020 | 171.13M | +63.93% |
| Dec 31, 2019 | 104.39M | +1270.14% |
| Dec 31, 2018 | 7.62M | -24.82% |
| Dec 31, 2017 | 10.13M | -28.73% |
| Dec 31, 2016 | 14.22M | -17.96% |
| Dec 31, 2015 | 17.33M | +Infinity% |
| Dec 31, 2014 | 0 | n/a |
| Dec 31, 2013 | 0 | n/a |